Anna Charalambous

2.1k total citations · 1 hit paper
17 papers, 1.7k citations indexed

About

Anna Charalambous is a scholar working on Immunology, Molecular Biology and Cell Biology. According to data from OpenAlex, Anna Charalambous has authored 17 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Molecular Biology and 4 papers in Cell Biology. Recurrent topics in Anna Charalambous's work include Immunotherapy and Immune Responses (5 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Quantum Dots Synthesis And Properties (3 papers). Anna Charalambous is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Quantum Dots Synthesis And Properties (3 papers). Anna Charalambous collaborates with scholars based in Cyprus, United States and Serbia. Anna Charalambous's co-authors include Ralph M. Steinman, Thomas M. Moran, Shin‐ichiro Fujii, Bruno Moltedo, Laura C. Bonifaz, Marie K. Brimnes, Helena Soares, Sundar Jagannath, Radek Špíšek and Madhav V. Dhodapkar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Anna Charalambous

16 papers receiving 1.7k citations

Hit Papers

In Vivo Targeting of Antigens to Maturing Dendritic Cells... 2004 2026 2011 2018 2004 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Charalambous Cyprus 11 1.2k 532 364 144 143 17 1.7k
Nurit Hollander Israel 18 790 0.7× 418 0.8× 184 0.5× 88 0.6× 87 0.6× 54 1.6k
Mathew Clement United Kingdom 21 941 0.8× 408 0.8× 392 1.1× 275 1.9× 57 0.4× 36 1.5k
L E Mobraaten United States 15 702 0.6× 713 1.3× 354 1.0× 101 0.7× 95 0.7× 28 2.1k
Alka Saxena United Kingdom 23 357 0.3× 1.4k 2.6× 290 0.8× 356 2.5× 94 0.7× 45 2.3k
Nico J. Stam Netherlands 18 1.8k 1.5× 689 1.3× 342 0.9× 247 1.7× 163 1.1× 21 2.5k
Tetyana V. Obukhanych United States 8 361 0.3× 862 1.6× 71 0.2× 70 0.5× 33 0.2× 8 1.7k
Elizabeth Di Lullo United States 11 488 0.4× 1.7k 3.2× 249 0.7× 247 1.7× 331 2.3× 12 3.1k
Ronald S. Murray United States 18 759 0.6× 239 0.4× 255 0.7× 270 1.9× 50 0.3× 34 1.8k
Amy Braun Canada 7 822 0.7× 931 1.8× 313 0.9× 156 1.1× 38 0.3× 14 1.6k
Katrin Vogt Germany 25 738 0.6× 347 0.7× 200 0.5× 230 1.6× 324 2.3× 57 1.8k

Countries citing papers authored by Anna Charalambous

Since Specialization
Citations

This map shows the geographic impact of Anna Charalambous's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Charalambous with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Charalambous more than expected).

Fields of papers citing papers by Anna Charalambous

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Charalambous. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Charalambous. The network helps show where Anna Charalambous may publish in the future.

Co-authorship network of co-authors of Anna Charalambous

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Charalambous. A scholar is included among the top collaborators of Anna Charalambous based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Charalambous. Anna Charalambous is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Charalambous, Anna, et al.. (2025). Targeting the hydrophobic pockets of FAK/PYK2 FAT domain: a highly effective inhibitory strategy suppressing tumor growth and eliminating metastasis. Cell Communication and Signaling. 23(1). 231–231. 1 indexed citations
2.
Charalambous, Anna, et al.. (2023). Dietary Stimuli, Intestinal Bacteria and Peptide Hormones Regulate Female Drosophila Defecation Rate. Metabolites. 13(2). 264–264. 2 indexed citations
3.
4.
Charalambous, Anna, et al.. (2021). FAK displacement from focal adhesions: a promising strategy to target processes implicated in cancer progression and metastasis. Cell Communication and Signaling. 19(1). 3–3. 14 indexed citations
5.
Charalambous, Anna, et al.. (2019). Methods of Calpain Inhibition to Determine the Role of Calpains in Embryo Development in Amphibians. Methods in molecular biology. 1915. 249–259.
6.
Charalambous, Anna, Maria Koyioni, Lidia S. Konstantinova, et al.. (2015). 1,2,3-Dithiazoles – new reversible melanin synthesis inhibitors: a chemical genomics study. MedChemComm. 6(5). 935–946. 13 indexed citations
7.
Charalambous, Anna, et al.. (2012). In Vivo, Site-Specific, Covalent Conjugation of Quantum Dots to Proteins via Split-Intein Splicing. Methods in molecular biology. 906. 157–169. 8 indexed citations
8.
Ioannou, Andriani, et al.. (2012). High-Resolution Whole-MountIn SituHybridization Using Quantum Dot Nanocrystals. SHILAP Revista de lepidopterología. 2012. 1–9. 4 indexed citations
9.
Charalambous, Anna, et al.. (2011). Split-Inteins for Simultaneous, site-specific conjugation of Quantum Dots to multiple protein targets In vivo. Journal of Nanobiotechnology. 9(1). 37–37. 16 indexed citations
10.
Wang, Bei, et al.. (2009). The Human Cancer Antigen Mesothelin Is More Efficiently Presented to the Mouse Immune System when Targeted to the DEC‐205/CD205 Receptor on Dendritic Cells. Annals of the New York Academy of Sciences. 1174(1). 6–17. 44 indexed citations
11.
Charalambous, Anna, Μαρία Ανδρέου, & Paris A. Skourides. (2009). Intein-mediated site-specific conjugation of Quantum Dots to proteins in vivo. Journal of Nanobiotechnology. 7(1). 9–9. 23 indexed citations
12.
Špíšek, Radek, Anna Charalambous, Amitabha Mazumder, et al.. (2007). Bortezomib enhances dendritic cell (DC)–mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications. Blood. 109(11). 4839–4845. 311 indexed citations
13.
Charalambous, Anna, Margarita Oks, Godwin Nchinda, Sayuri Yamazaki, & Ralph M. Steinman. (2006). Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin. The Journal of Immunology. 177(12). 8410–8421. 59 indexed citations
14.
Liu, Kang, Juliana Idoyaga, Anna Charalambous, et al.. (2005). Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells. The Journal of Experimental Medicine. 202(11). 1507–1516. 87 indexed citations
15.
Bonifaz, Laura C., Anna Charalambous, Shin‐ichiro Fujii, et al.. (2004). In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination. The Journal of Experimental Medicine. 199(6). 815–824. 729 indexed citations breakdown →
16.
Hall, Diana, et al.. (2003). Sequence Variants of the Brain-Derived Neurotrophic Factor (BDNF) Gene Are Strongly Associated with Obsessive-Compulsive Disorder. The American Journal of Human Genetics. 73(2). 370–376. 213 indexed citations
17.
Kang, Young‐Sun, Jae Y. Kim, Maggi Pack, et al.. (2003). The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide ofStreptococcus pneumoniaein the marginal zone of mouse spleen. Proceedings of the National Academy of Sciences. 101(1). 215–220. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026